| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8516567 | Neuropharmacology | 2018 | 43 Pages |
Abstract
This article is part of the Special Issue entitled 'Metabolic Impairment as Risk Factors for Neurodegenerative Disorders.'
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Dilan Athauda, Thomas Foltynie,